TABLE 2.

Univariate and Multivariate Predictors for Clinical Remission at Week 52

	Univariate Analyses			Multivariate Analyses
	OR	95% CI	P	OR	95% CI	P
Age >37 years at inclusion	1.09	0.21–6.00	1
Sex—male	0.65	0.12–3.61	0.709
Disease duration, >9 years	0.11	0.01–0.69	0.008
Disease location
Ileum	2.42	0.27–22.3	0.363
Ileocolonic	0.54	0.09–3.03	0.459
Colon	1.05	0.08–9.08	1
Disease behavior
Inflammatory disease	5.23	0.76–44.4	0.079
Stricturing disease	0.42	0.06–2.36	0.295
Penetrating disease	0.59	0.08–3.40	0.705
Perianal disease	1.58	0.30–9.54	0.715
Anal fistula	0.59	0.08–3.40	0.705
Prior intestinal resections	0.21	0.03–1.19	0.066
Prior biologics
Naive to anti-TNF agents	7.67	0.53–450.7	0.089
2 anti-TNF agents	0.18	0.02–1.15	0.064
Disease activity
CDAI score >340 at baseline	0.52	0.04–3.59	0.682
CRP >0.5mg/dL at baseline	2.82	0.50–20.8	0.271
Albumin ≥3.8mg/dL at baseline	2.63	0.38–18.7	0.388
SES-CD score >10 at baseline	0.53	0.06–4.21	0.659
70-point response at week 8	10.4	1.51–127.4	0.007
Clinical remission at week 8	21.0	2.57–202.4	<0.001	24.5	3.37–178.0	0.002
CRP >0.5mg/dL at week 8	0.29	0.04–1.67	0.141
Albumin ≥3.8mg/dL at week 8	13.0	1.83–163.7	0.005
Concomitant medication
5-aminosalicylic acid	0.94	0.17–5.74	1
Enteral nutrition (≥900 kcal/day)	0.89	0.15–4.84	1
Corticosteroids or budesonide	1.83	0.35–10.2	0.475
Immunosuppressants	0.53	0.09–2.82	0.477